Unlike ACE inhibitors, ARBs, a class of medication that has been used to lower blood pressure and reduce proteinuria, left ventricular hypertrophy, and improve outcomes in heart failure, do not affect bradykinin levels but instead block the action of angiotensin II [10]. This evidence concerns the gene ACE and left ventricular hypertrophy.